Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting João Morais, Carlos Aguiar, Euan McLeod, Ismini Chatzitheofilou, Isabel Fonseca Santos, Sónia Pereira

Antithrombotic therapy in nonvalvular atrial fibrillation: A narrative review Susana P.D. Sá, Rui P. Rodrigues, João Santos-Antunes, Francisco Rocha Gonçalves, José Pedro L. Nunes

Edoxaban Treatment in routiNe clinical prActice in patients with non-valvular Atrial Fibrillation (ETNA-AF) in Iberia: Baseline data Pedro Monteiro